Follow the Chromocell Therapeutics Corp stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 16 September 2024 (Acquisition). Among the most active insiders: Francis Knuettel II. Every trade is free.
7
Insider Decl.
n/a
Thresholds
€108,088
4 ops.
Buy Volume
n/a
n/a
Sell Volume
46Σ signal
Buys €108,088n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.